CymitQuimica logo
Cellule staminali e Derivati

Cellule staminali e Derivati

Gli inibitori delle cellule staminali sono composti che bersagliano specificamente le vie di segnalazione e le proteine coinvolte nel mantenimento, nella differenziazione e nella proliferazione delle cellule staminali. Questi inibitori sono cruciali per comprendere la biologia delle cellule staminali e per sviluppare strategie per manipolare le cellule staminali a fini terapeutici, come la medicina rigenerativa e il trattamento del cancro. Controllando il destino delle cellule staminali, questi inibitori possono aiutare a guidare la differenziazione delle cellule staminali in tipi cellulari specifici o a prevenire una crescita cellulare indesiderata. Presso CymitQuimica, offriamo una selezione di inibitori delle cellule staminali di alta qualità per supportare la tua ricerca in biologia delle cellule staminali, biologia dello sviluppo e medicina rigenerativa.

Sottocategorie di "Cellule staminali e Derivati"

Mostrare 2 più sottocategorie

Trovati 692 prodotti di "Cellule staminali e Derivati"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • TK4g

    CAS:
    <p>TK4g, a potent JAK inhibitor, has IC50s of 12.61 nM (JAK2) &amp; 15.80 nM (JAK3); promising for lymphoid diseases &amp; leukemia research.</p>
    Formula:C19H19N3O4S
    Colore e forma:Solid
    Peso molecolare:385.44
  • γ-Secretase modulator 4

    CAS:
    <p>γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.</p>
    Formula:C23H19FN4O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:402.42
  • tCFA15

    CAS:
    tCFA15: A trimethylated long-chain fatty alcohol with a 15-carbon side chain; may regulate Notch signaling and neuron differentiation.
    Formula:C24H44O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:364.61
  • γ-secretase modulator 2

    CAS:
    <p>Gamma-secretase modulator 2 selectively targets Alzheimer's by reducing Aβ(1-42), aiding in prevention and treatment.</p>
    Formula:C25H22F4N6O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:514.47
  • JAK-IN-18

    CAS:
    <p>"JAK-IN-18: potent JAK inhibitor for eye, skin, respiratory disease research (WO2018204238A1, comp 1)."</p>
    Formula:C27H28F2N6O3
    Colore e forma:Solid
    Peso molecolare:522.55
  • LY-411575 isomer 1

    CAS:
    <p>LY-411575 isomer 1 is a potent γ-secretase inhibitor. LY-411575 isomer 1 is an isomer of LY411575.</p>
    Formula:C26H23F2N3O4
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:479.48
  • JAK3-IN-12

    CAS:
    <p>JAK3-IN-12 (compound 15k) is a potent inhibitor of JAK3 (IC50: 9.5 nM) and can be used in the study of rheumatoid arthritis.</p>
    Formula:C19H19N5O4S
    Colore e forma:Solid
    Peso molecolare:413.45
  • ELN318463

    CAS:
    <p>ELN 318463 selectively inhibits γ-secretase; EC50: 12 nM (PS1), 656 nM (PS2); 51x more selective for PS1; targets APP.</p>
    Formula:C19H20BrClN2O3S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:471.8
  • Tyk2-IN-5

    CAS:
    Tyk2-IN-5 is a selective and orally active inhibitor of Tyk2 JH2 (Ki: 0.086 nM for Tyk2 JH2; IC50: 25 nM for IFNα).
    Formula:C21H19FN8O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:434.43
  • JAK-IN-14

    CAS:
    <p>JAK-IN-14 (compound 16) is a specific JAK1 inhibitor. It prevents JAK1 phosphorylation by binding to the active site of JAK in immune, inflammation and cancer.</p>
    Formula:C19H15FN4O
    Purezza:98.27%
    Colore e forma:Solid
    Peso molecolare:334.35
  • OICR-0547

    CAS:
    <p>OICR-0547 is an inactive derivative of OICR-9429 and is commonly used as a negative control for OICR-9429.</p>
    Formula:C28H29F3N4O4
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:542.55
  • EP009

    CAS:
    <p>EP009, a novel, selective, and orally active inhibitor of JAK3, induces therapeutic response in T-cell malignancies.</p>
    Formula:C14H24O2
    Colore e forma:Solid
    Peso molecolare:224.34
  • Tyk2-IN-7

    CAS:
    Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM).
    Formula:C18H15D3N6O3S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:401.46
  • 3F8

    CAS:
    <p>3F8 is a selective GSK-3β inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in</p>
    Formula:C15H14N2O4
    Purezza:98.14% - 98.25%
    Colore e forma:Solid
    Peso molecolare:286.28
  • MS-1020

    CAS:
    MS-1020 inhibits JAK3/STAT3, blocks active JAK3, suppresses JAK3/STAT5 signaling, and targets STAT3 in certain cells.
    Formula:C21H18N2O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:346.38
  • 1,2,3,4,5,6-Hexabromocyclohexane

    CAS:
    <p>Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.</p>
    Formula:C6H6Br6
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:557.54
  • INCB16562

    CAS:
    <p>INCB16562: oral JAK1/2 inhibitor, halts IL-6/STAT3 in myeloma cells, boosts drug efficacy, stunts myeloma in mice.</p>
    Formula:C19H11Cl2N5
    Colore e forma:Solid
    Peso molecolare:380.23
  • JAK3-IN-9

    CAS:
    <p>JAK3-IN-9, potent JAK3 inhibitor, IC50 of 1.7 nM, highly selective, low toxicity, orally bioavailable, shows anti-arthritis activity.</p>
    Formula:C17H23N5O4S
    Colore e forma:Solid
    Peso molecolare:393.46
  • RR-11a analog

    CAS:
    <p>RR-11a (aza-peptide) inhibits asparaginyl endopeptidase: IC50 - 4.5 nM (T. Vaginalis, I. ricinus), 31 nM (S. mansoni).</p>
    Formula:C22H29N5O8
    Purezza:98.80%
    Colore e forma:Solid
    Peso molecolare:491.49
  • TGFβRI-IN-1

    CAS:
    <p>TGFβRI-IN-1 is an oral active and selective inhibitor of TGFβ receptor type I (TGFβRI) kinase(IC50 values of 2 nM and 7.6 μM for TGFβRI and TGFβRII,</p>
    Formula:C20H14D3N5O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:362.4